Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.

Recruiting now

Conditions studied: Genitourinary Cancers

In brief

SOGUG-PRINCIS is a retrospective (regarding patient inclusion) and prospective follow-up, epidemiological, non-interventional, non-blinded, non-randomized, multicenter, national observational study with drugs. This study will collect data from patients with genitourinary tumors to analyze the effectiveness under routine clinical practice conditions of drugs recently approved for funding in the Spanish National Health System. In all cases, the decision to start treatment will be made prior to and independently of participation in the study, which will be limited to subsequently collecting the data necessary to assess the objectives of the study. This study will serve as a registry for genitourinary cancers. Every time a new drug will be authorized, a new subproject with a primary endpoint will be opened to recruitment. The substudy will try to validate with real-world data the endpoints reported in the phase III clinical trials that led to the marketin authorization.

Key facts

Study ID: NCT06724159
Run by: Spanish Oncology Genito-Urinary Group
People needed: 500
Starts: 2024-12-13
Expected to finish: 2027-12-01
Last updated by the study team: 2026-02-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Patients ≥18 years old.
Patients granting the ICF unless exemption or exceptions mentioned below.
Histological diagnosis of malignant neoplasia originating in the genitourinary system: kidney, renal pelvis, ureter, bladder, prostate, testicle and germinal tissue of other locations, urethra, penis, or seminal vesicles.
Patients have started treatment with medications whose positive resolution of financing by the Spanish National Health System for the aforementioned tumors has been after January 1, 2023.
Patients have started treatment after the official publication of the positive resolution of financing of the drug under study by the National Health System. This restriction is intended to avoid interference of the study with the marketing authorization processes by the European Medicines Agency, and price and reimbursement negotiations by the Spanish health authorities.
Patients have received treatment at the participating center.

You may not qualify if…

Patients previously treated at another centre who have subsequently been referred to one of the participating centres. In this case, the patient will be included in the centre where treatment was started, or in the second centre if the first is not part of this study.
Patients who do not meet any of the inclusion criteria.
Evidence of an express objection by the subject or his/her legal representative to participate in the study.

Where it is running

Complejo Hospitalario Universitario de Albacete — Albacete, Albacete, Spain (enrolling)
Hospital Universitario Torrecárdenas — Almería, Andalusia, Spain (enrolling)
Hospital Universitario Reina Sofía — Córdoba, Andalusia, Spain (enrolling)
Hospital General Universitario de Alicante — Alicante, Alicante, Spain (enrolling)
Hospital Universitario Virgen a de las Nieves — Granada, Andalusia, Spain (enrolling)
Hospital Universitario de Jaén — Jaén, Andalusia, Spain (enrolling)
Hospital Universitario Jerez de la Frontera — Jerez de la Frontera, Andalusia, Spain (enrolling)
Hospital Universitario Virgen de la Victoria — Málaga, Andalusia, Spain (enrolling)
Hospital Universitario Virgen Macarena — Seville, Andalusia, Spain (enrolling)
Hospital Universitario Clínico San Cecilio — Granada, Andalusia, Spain (enrolling)
Hospital Universitario Virgen del Rocío — Seville, Andalusia, Spain (enrolling)
Hospital Universitario Virgen de Valme — Seville, Andalusia, Spain (enrolling)
Hospital Universitario San Jorge — Huesca, Aragon, Spain (enrolling)
Hospital Clínico Universitario Lozano Blesa — Zaragoza, Aragon, Spain (enrolling)
Hospital Universitario Miguel Servet — Zaragoza, Aragon, Spain (enrolling)
Hospital General Mateu Orfila — Mahón, Balearic Islands, Spain (enrolling)
Hospital Son Espases — Palma de Mallorca, Balearic Islands, Spain (enrolling)
Hospital Universitario Son Llàtzer — Palma de Mallorca, Balearic Islands, Spain (enrolling)
Hospital Universitario de Cruces — Barakaldo, Basque Country, Spain (enrolling)
Hospital Universitario Basurto — Bilbao, Basque Country, Spain (enrolling)
OSI Donostialdea - Onkologikoa — Donostia / San Sebastian, Basque Country, Spain (enrolling)
Hospital Galdakao-Usansolo Ospitalea — Galdakao, Basque Country, Spain (enrolling)
Hospital Universitario de Álava - Txagorritxu — Vitoria-Gasteiz, Basque Country, Spain (enrolling)
Hospital Materno Infantil de Gran Canaria — Las Palmas de Gran Canaria, Canary Islands, Spain (enrolling)
Hospital Universitario de Burgos — Burgos, Castille and León, Spain (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.